Castle Biosciences, Inc. (NASDAQ:CSTL)’s Dx-Melanoma test, which evaluates a 31-gene expression profile, offers significant, ...

Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces its first quarter 2025 financial results. First Quarter 2025 ...

The biotechnology company BeiGene, founded in China, is moving its legal headquarters from the Cayman Islands to Basel.

Revelation Biosciences, Inc. (NASDAQ:REVB), a clinical-stage life sciences company dedicated to rebalancing inflammation for ...

Colossal Biosciences is a trailblazing company that's pushing the boundaries of genetic engineering and shattering them.